Hello Visitors! Welcome to REPRODUCTIVE RIGHTS ALERTS.

Welcome to RRA! Get all of your latest reproductive news here from a variety of news outlets. We started this website in order to help those who care about reproductive rights stay informed, stay educated, and stay updated!This website is run entirely by volunteers, and sponsored by Toby's Fund for Reproductive Health Equity! It's over 1 year since we started! The Fight CONTINUES! We start to understand the war on reproductive rights. We start to continue our community of people who wish fairness; We start to coalesce on strategies to bring humanity back to the United States!
Read More

Virginia District Court Rules FDA Unlawfully Restricted Abortion Pill Access

A Virginia district court judge ordered the FDA to reconsider its restrictions on mifepristone, a highly safe and effective prescription medication for terminating early pregnancy. The judge, Robert S. Ballou, sided with reproductive health clinics in three states that argued that current restrictions are excessive, medically unnecessary, and inconsistent with federal law. The challenged restrictions are part of FDA’s 2023 risk evaluation mitigation strategy (2023 REMS).
Read More

Health Care Financing to Improve Availability of Affordable Contraception: Identifying Promising Practices

Effective family planning that meets an individual’s needs, values, and preferences is a critical element of high-quality health care for women. Despite the well-documented role of family planning in improving maternal and infant health outcomes, persistent financial obstacles create barriers to care for many women. An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will review programs that aim to improve availability and affordability of contraception and identify effective strategies to inform future policy and practice.
Read More

In wide-ranging amicus briefs, experts again urge the Fifth Circuit to reject restrictions on telehealth access to mifepristone

Ahead of oral argument in Louisiana v. U.S. Food and Drug Administration (FDA) on September 9, a wide range of experts — including the American College of Obstetricians and Gynecologists, American College of Emergency Physicians, the National Domestic Violence Hotline, the Disability Rights Education & Defense Fund, the NAACP Legal Defense & Educational Fund, pharmaceutical and biotech manufacturers, and former military officials — are urging the U.S. Court of Appeals for the Fifth Circuit to reject anti-abortion politicians’ effort to end telemedicine and mail and pharmacy access to mifepristone nationwide.Mifepristone is used in nearly two-thirds of U.S. abortions, with more than 1 in 4 patients
Read More

Reproductive Freedom for All Launches Ad in Pennsylvania Highlighting FDA Nominee Heidi Overton’s Anti-Abortion Extremism

Reproductive Freedom for All launched a new digital ad in Pennsylvania, “Victory“, highlighting the anti-abortion extremism of Heidi Overton, Donald Trump’s nominee to lead the Food and Drug Administration. Overton has pushed disinformation about the safety of medication abortion and argued for remaking federal health agencies around Republicans’ anti-abortion agenda. If confirmed, she would run an agency that could entirely curb access to mifepristone—in effect pushing a backdoor abortion ban that is deeply unpopular with voters.
Read More

Shapiro challenges Trump admin on reproductive health care funding

 On August 27, Gov. Josh Shapiro sued the U.S. Department of Health and Human Services (HHS) over its attempt to restrict federal funding for reproductive health care and family planning services. In July, the Trump Administration announced new terms and conditions on Title X grants for the 2027-2032 grant cycle, attempting to restrict access to reproductive health care in order advance the Trump Administration’s political agenda.
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.